Switzerland
Blue Ocean invests in Abionic
Swiss private equity and venture capital medtech investor MedHoldings led the round
Molecular Partners launches Swiss IPO
Venture-capital backed biotech plans to raise CHF 125m for R&D
HC Royalty injects €45m into Cardiorentis
Swiss company focuses on treatments for acute heart failure
Neomed’s fifth fund holds €92m final close
Fund closed on slightly less than its predecessor
Permira-backed Mesa acquires MVS
Mesa and UK-based Asteral merged in August with Permira's support
SHS invests in TRI Dental Implants
GP invests via SHS-IV vehicle, due to close this year
ArchiMed acquires Medistream for €12m
France-based GP makes maiden investment
Metric Capital backs Signalhorn
Maiden investment from the GP's second fund
Constellation acquires Roth Brandschutz
MBO solves owner's succession planning quandary
Gimv et al. exit Covagen in trade sale
Covagen raised CHF 58.9m prior to sale
Nordic Capital carves out Full Service from ABB
Company will take new name and move to Stockholm
VC-backed EyeEm bolts on sight.io
EyeEm has hired sight.io founder as R&D head
Auris’ delayed IPO lists below initial price range
Number of shares on offer increased by more than 35% but price almost halved
Omega backs Andrew Alliance’s series-B
Cash injection will enable the business to open new Boston office
Auris Medical ‘delays’ IPO
Listing could take place this week
Permira backs pan-European healthcare merger
Permira-backed newco will unite Mesa Group and Asteral
GetYourGuide raises $25m series-B
Company has grown through two acquisitions
Carlyle’s Varo Energy bolts on Total assets
GP did not provide additional funding for deal
CGS acquires majority stake in Masa
Acquisition in line with CGS's experience in sector
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
KKR acquires 49% of Ringier Digital subsidiaries
Investment made via €4.8bn European Fund III
Akina’s Euro Choice Secondary holds €73.5m first close
News comes a few months after Euro Choice V final close
Invoke Capital et al. inject $14m into Sophia Genetics
Swisscom and Endeavour Vision also take part in series-B
KKR exits Wild Flavors in €2.3bn trade sale
ADM acquired ingredients company to diversify product portfolio